Rett Syndrome Research Trust Joins the Bespoke Gene Therapy Consortium

Trumbull, CT (PRWEB) February 03, 2022 -- The Rett Syndrome Research Trust (RSRT) has joined the Accelerating Medicines Partnership® Bespoke Gene Therapy

Related Keywords

United States , ,Bespoke Gene Therapy Consortium ,Foundation For The National Institutes Of Health ,National Institutes Of Health ,Drug Administration ,Medicines Partnership ,Medicines Partnership Program ,Rett Syndrome Research Trust ,Accelerating Medicines Partnership ,National Institutes ,Randall Carpenter ,Gene Therapies ,Accelerating Medicines Partnership Program ,Press Release ,